Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer
Condition: HER2-positive Breast Cancer Interventions: Drug: Docetaxel; Drug: Carboplatin; Drug: Trastuzumab; Drug: Pertuzumab; Drug: Trastuzumab emtansine Sponsor: University of Rochester Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | HER2 | Herceptin | Research | Taxotere